Lamivudine
Lamivudine · Say it: la-MIV-yoo-deen
A prescription antiviral tablet used to treat long-term (chronic) hepatitis B virus infection when the virus is active and the liver is inflamed.
⬛ Boxed warning (the FDA's strongest warning)
The boxed warning covers two risks. First, severe acute flare-ups of hepatitis B have been reported in patients who stopped anti-hepatitis B treatment, including lamivudine. Liver function should be watched closely with clinical and lab follow-up for at least several months after stopping, and starting other hepatitis B treatment may be needed. Second, lamivudine tablets (HBV) are not approved to treat HIV-1. Because the dose is lower than HIV-treatment doses and it is used alone, HIV-1 resistance may develop in people who have unrecognized or untreated HIV-1. HIV counseling and testing should be offered before starting and periodically during treatment.
Used for
The label says this tablet treats chronic hepatitis B virus (HBV) infection with evidence of hepatitis B viral replication and active liver inflammation. The label says it is not approved to treat HIV-1 infection. It has not been studied in people who also have HIV, hepatitis C, or hepatitis delta virus, in liver transplant recipients, or in people with decompensated (severely damaged) liver disease. The label also says it is not known to be safe and effective in children under 2 years old with chronic HBV.
Comes as
Tablets: 100 mg, pink, capsule-shaped, film-coated tablets, marked with '37' on one side and 'I' on the other; The label also mentions an oral solution for some pediatric patients (not described in detail in this label)
Common side effects
Ear, nose, and throat infections (25% of people on the medicine vs. 21% on placebo in the trials), Sore throat (13% vs. 8% on placebo), Diarrhea (14% vs. 12% on placebo)
| Generic name | Lamivudine |
|---|---|
| Brand names | — |
| Type of medicine | An antiviral medicine of the nucleoside analogue reverse transcriptase inhibitor type, used here for hepatitis B |
| How it is sold | Prescription medicine (tablet taken by mouth) |
| Comes as | Tablets: 100 mg, pink, capsule-shaped, film-coated tablets, marked with '37' on one side and 'I' on the other; The label also mentions an oral solution for some pediatric patients (not described in detail in this label) |
| Route | oral |
| Boxed warning | Yes, see below |
| Label date | 2026-07-29 |
💊 What is Lamivudine used for?
- The label says this tablet treats chronic hepatitis B virus (HBV) infection with evidence of hepatitis B viral replication and active liver inflammation. The label says it is not approved to treat HIV-1 infection. It has not been studied in people who also have HIV, hepatitis C, or hepatitis delta virus, in liver transplant recipients, or in people with decompensated (severely damaged) liver disease. The label also says it is not known to be safe and effective in children under 2 years old with chronic HBV.
How it works
The label describes lamivudine as a synthetic nucleoside analogue with activity against HBV. The label excerpt provided does not explain its effects in more detail.
How it is usually taken
- The label says lamivudine tablets (HBV) may be taken with or without food. The tablet is taken by mouth. The label says doses depend on age, body weight, and kidney function, so the amount is set by your prescriber. Follow the instructions from your prescriber or pharmacist. Children who need a lower amount or who cannot swallow tablets may be prescribed the oral solution instead.
Comes as
- Tablets: 100 mg, pink, capsule-shaped, film-coated tablets, marked with '37' on one side and 'I' on the other
- The label also mentions an oral solution for some pediatric patients (not described in detail in this label)
⚠️ Lamivudine side effects
Common side effects
- Ear, nose, and throat infections (25% of people on the medicine vs. 21% on placebo in the trials)
- Sore throat (13% vs. 8% on placebo)
- Diarrhea (14% vs. 12% on placebo)
- Some lab changes were seen more often than with placebo, including higher serum lipase, higher creatine phosphokinase (CPK), and lower platelet counts
Get medical help right away if
- Get medical help right away if your hepatitis B gets worse or you have a severe liver flare-up, especially after stopping the medicine. The label says this can be serious and may lead to death.
- Get medical help right away if you develop new or worsening symptoms of liver disease. The label says the hepatitis B virus can change and become resistant, which can worsen liver disease.
- Get medical help right away if you have symptoms suggesting lactic acidosis or severe liver toxicity. The label says these conditions, including fatal cases, have been reported with nucleoside analogues. The label advises stopping the medicine if these symptoms appear, so contact your prescriber right away.
🛑 Who should not take Lamivudine, and who should be careful
The label says not to take it if
- You have had a previous allergic (hypersensitivity) reaction to lamivudine
- You are taking other medicines that contain lamivudine or emtricitabine. The label says lamivudine tablets (HBV) should not be used with these.
Tell your doctor before taking it if
- Tell your prescriber if you have or might have HIV. The label says HIV testing should be offered before starting and during treatment.
- Tell your prescriber about kidney problems, since the label says doses must be adjusted based on kidney function.
- Tell your prescriber about all prescription, non-prescription, and herbal products you use.
- Tell your prescriber if you are pregnant or planning a pregnancy.
- Do not stop this medicine without first telling your healthcare provider. The label warns that stopping can cause severe liver flare-ups.
- The label says treatment has not been shown to reduce the risk of spreading HBV to others through sexual contact or blood contamination.
🔀 Lamivudine with other medicines, food and alcohol
The label says to discuss these with your doctor or pharmacist
- Sorbitol-containing medicines (prescription or over-the-counter): The label says these may lower lamivudine levels. The label advises avoiding chronic use when possible, and considering more frequent monitoring of HBV viral load if it cannot be avoided.
- Trimethoprim and other drugs cleared by the kidneys through the same transport system: The label says interactions are possible and should be considered.
- Medicines that contain lamivudine or emtricitabine: The label says they should not be used together with this medicine.
- The label asks patients to report any prescription, non-prescription, or herbal products to their healthcare provider.
Alcohol and food
The label says lamivudine tablets (HBV) may be taken with or without food. The label does not give information about alcohol.
🤰 Lamivudine in pregnancy and breastfeeding
Pregnancy
The label describes a pregnancy exposure registry (Antiretroviral Pregnancy Registry, 1-800-258-4263) that tracks pregnancy outcomes. The label says registry data show no substantial difference in overall major birth defect risk compared with the background rate, but most women in the registry were treated for HIV at higher doses. The label says the rate of miscarriage with lamivudine is unknown. Talk with your prescriber about pregnancy plans.
Breastfeeding
The label does not say.
🗓️ Storage, missed doses and taking too much
Storage
Store at 20 to 25 degrees C (68 to 77 degrees F), at controlled room temperature. Keep in a well-closed, light-resistant container.
If a dose is missed
The label says to take a missed dose as soon as you remember. Do not double your next dose or take more than the prescribed dose. Ask your prescriber or pharmacist if you have questions.
If too much is taken
The label says there is no known specific treatment for an overdose. If an overdose happens, the person should be monitored and given standard supportive treatment as needed. The label says only a negligible amount of lamivudine was removed by dialysis, so it is not known whether continuous hemodialysis would help.
🗒️ Questions to ask about Lamivudine
🎯 Check what you understood
1. According to the boxed warning, what can happen if someone stops anti-hepatitis B treatment?
2. Is lamivudine tablets (HBV) approved to treat HIV-1 infection?
3. What does the label say about taking this tablet with food?
❓ Lamivudine: frequently asked questions
Can I stop taking lamivudine on my own?
The label advises patients not to stop lamivudine tablets (HBV) without first informing their healthcare provider. The label warns that stopping can cause severe liver flare-ups.
What are the most common side effects?
The label lists ear, nose, and throat infections, sore throat, and diarrhea as the most common side effects seen more often than with placebo in the trials.
Do I need an HIV test before taking this medicine?
The label says HIV counseling and testing should be offered to all patients before beginning treatment and periodically during treatment. This is because HIV-1 resistance may develop in people with untreated HIV-1.
What should I do if I miss a dose?
The label says to take the missed dose as soon as you remember. Do not double the next dose or take more than the prescribed dose.
How should I store this medicine?
The label says to store it at 20 to 25 degrees C (68 to 77 degrees F) in a well-closed, light-resistant container.
🧪 Tests and reports linked to Lamivudine
The label text mentions these. If you have one of these reports, get every line of it explained.
- Culture and sensitivity
a test or report linked to this medicine
- Urinalysis
a test or report linked to this medicine
- HIV tests
a test or report linked to this medicine
- Hepatitis panel
a test or report linked to this medicine
- Liver function tests
a test or report linked to this medicine
- Kidney function tests
a test or report linked to this medicine
📖 Medical words used on this page
- Acute vs chronic
Acute means something started recently or suddenly. Chronic means it has lasted a long time or keeps coming back.
- Antiretroviral
An antiretroviral is a medicine that stops HIV from multiplying. Combinations of them, called ART, keep HIV under control long-term.
- Antiviral
An antiviral is a medicine that works against viruses, stopping them from multiplying. Different antivirals work against different viruses.
- Bilateral and unilateral
Bilateral means on both sides of the body and unilateral means on one side only, and reports usually also name the side.
- Boxed warning
A boxed warning is the strongest safety warning on a US medicine label, printed in a box, about a serious or life-threatening risk.
- Chronic hepatitis B
Chronic hepatitis B is a long-lasting liver infection with the hepatitis B virus, defined as infection lasting more than six months.
- Dialysis
Dialysis is a treatment that removes waste and extra fluid from the blood when the kidneys can no longer do this well enough.
- Edema
Edema is swelling caused by extra fluid trapped in the body's tissues, often in the feet, ankles and legs.
- Exacerbation
An exacerbation is a flare-up: a period when a long-term condition, such as asthma, COPD or hepatitis, suddenly gets worse.
- Film-coated
Film-coated means a tablet has a thin outer layer that makes it easier to swallow, masks taste, or protects the medicine inside.
- Follow-up appointment
A follow-up appointment is a planned visit after a test, treatment or hospital stay to check progress and decide next steps.
- Hemodialysis
Hemodialysis is a treatment where a machine filters the blood to remove waste and extra fluid when the kidneys cannot do it well enough.
- Hepatitis
Hepatitis means inflammation of the liver. It can be caused by viruses, alcohol, some medicines or the immune system.
- Hepatotoxicity
Hepatotoxicity means damage to the liver caused by a medicine, chemical or supplement.
📖 Medical words on this page
⚖️ Compare
Have the leaflet or prescription in front of you?
Explain my leafletDecode my prescription🔗 Trusted sources about Lamivudine
- Full official label on DailyMed ↗
US National Library of Medicine: the complete FDA label this page is based on
- Lamivudine on MedlinePlus ↗
US National Library of Medicine's patient drug information
- Search the NHS website for Lamivudine ↗
UK National Health Service
Report a side effect or check safety alerts
- Report a side effect in the US (FDA MedWatch) ↗
- Report a side effect in the UK (Yellow Card) ↗
- FDA recalls and safety alerts ↗
Explain your own documents
🔎 Look up another medicine
⭐ My medicines
Nothing saved yet.
🧩 Similar medicines
- Acyclovir · An antiviral medicine of the nucleoside analogue type, used against herpesviruses
- Tenofovir Disoproxil Fumarate · A nucleotide analog medicine. The label calls it an HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. The FDA class is not listed.
- Valacyclovir · an antiviral medicine. The label describes it as a deoxynucleoside analogue DNA polymerase inhibitor, and it is the hydrochloride salt of the L-valyl ester of acyclovir.
Source: official FDA drug label (label updated 2026-07-29). Read the full label on DailyMed
MedicDecode explains the official label in plain words. It is not medical advice and does not replace your doctor or pharmacist. Never start, stop or change a medicine because of what you read here.